Drug Type Small molecule drug |
Synonyms GRC-CPD-A, GRC-10693 |
Target |
Action agonists |
Mechanism CB2 agonists(Cannabinoid CB2 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H21F2N3O |
InChIKeyNTPZXHMTJGOMCJ-WDEREUQCSA-N |
CAS Registry916591-01-0 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Tedalinab | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammatory pain | Phase 1 | India | - | |
| Neuralgia | Phase 1 | European Union | - | |
| Osteoarthritis | Phase 1 | India | - | |
| Pain | Phase 1 | - | - |





